INTRODUCTION
2023 witnessed profound growth in the Dermatology and Aesthetics market, reaching a value of c.$35 billion globally, and is forecasted to be over $102 billion by 2035. In 2024, for M&A investors, this presents a remarkable opportunity to enter a sector with a long-term growing trajectory.
The fundamental drivers behind this long-term expansion include an ageing population, growing disposable incomes, health-conscious consumers, growth of non-invasive procedures and technological advancements.
The market is also experiencing historically high M&A volumes due to the strength and persistent consolidation opportunities. Underlying levers include the markets resilient nature; recovering quickly from economic downturns, untapped emerging markets, such as the Asia-pacific with significant potential growth, and continuous innovation spearheaded by advanced technologies that driver better consumer results.
To learn more about the key M&A trends taking shape this year in the Dermatology and Aesthetics space, read our latest paper.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.